【摘 要】
：
Angiotensin-converting enzyme functions in the male reproductive system, but the extent of its function in reproduction is not fully understood. The primary objective of this work was to investigate the relationship between the testicular isoform of angio
【机 构】
：
Department of Physiology, Faculty of Medicine and Nursery, University of the Basque Country (UPV/EHU
论文部分内容阅读
Angiotensin-converting enzyme functions in the male reproductive system, but the extent of its function in reproduction is not fully understood. The primary objective of this work was to investigate the relationship between the testicular isoform of angiotensin-converting enzyme present in human spermatozoa and semen parameters, human embryo quality, and assisted reproduction success. A total of 81 semen samples and 635 embryos from couples undergoing oocyte donation cycles at the IVI Bilbao Clinic were analyzed. Semen parameters, embryos quality, and blastocyst development were examined according to the World Health Organization standards and the Spanish Association of Reproduction Biology Studies criteria. The percentage of testicular angiotensin-converting enzyme-positive spermatozoa and the number of molecules per spermatozoon were analyzed by flow cytometry. Both parameters were inversely correlated with human sperm motility. Higher percentages of testicular angiotensin-converting enzyme-positive spermatozoa together with fewer enzyme molecules per spermatozoon were positively correlated with better embryo quality and development. Our results suggest that embryos with a higher implantation potential come from semen samples with higher percentages of testicular angiotensin-converting enzyme-positive cells and fewer enzyme molecules per spermatozoon. Based on these findings, we propose that testicular angiotensin-converting enzyme could be used to aid embryologists in selecting better semen samples for obtaining high-quality blastocysts during in vitro fertilization procedures.
其他文献
Prostate cancer is among the most common malignancies in Western countries,and its incidence is rapidly rising in Asia where it was traditionally considered an uncommon tumor.Our understanding of the disease and management strategies continue to evolve.Th
The prognostic significance of initial prostate-specific antigen (PSA) level for metastatic prostate cancer remains uncertain. We investigated the differences in prognosis and response to hormonal therapies of metastatic prostate cancer patients according
Dear Editor,rnCongenital bilateral absence of the vas deferens (CBAVD),a complete or partial defect of the Wolffian duct derivatives,is found in ＞25％ of men with obstructive azoospermia (OA),but the underlying pathological mechanism remains poorly underst
Dear Editor,rnIntrauterine insemination (IUI) is mainly indicated in cases of unexplained or mild male subfertility. In these cases, gonadotropin ovarian stimulation combined with gonadotropin-releasing hormone (GnRH) antagonist IUI leads to up to an 18％
Late-onset hypogonadism (LOH) has been described as a clinical syndrome comprising symptoms consistent with androgen deficiency and a circulating concentration of testosterone in the low-to-normal range insome middle-aged and elderly men.
The current literature does not support the usefulness of clinical markers on predicting which patients with atypical small acinar proliferation (ASAP) are more likely to progress to prostate cancer (PCa). Androgens have long been considered to be the pot
Urge urinary incontinence (UUl) is one of the most troublesome complications of surgery of the prostate whether for malignancy or benign conditions.For many decades,there have been attempts to reduce the morbidity of this outcome with variable results.Sin
Autologous tissue engineering using biodegradable scaffolds as a carrier is a well-known procedure for penile girth enhancement. We evaluated a group of previously treated patients with the aim to analyze histomorphometric changes after tissue remodeling
We evaluated contemporary trends in radical prostatectomy (RP) in men aged ＞70 years and investigated associations of selected variables with recovery of urinary continence (UC) in two age groups:＞70 and ≤70 years.A retrospective cohort of 2301 eligible p